Acular (ketorolac tromethamine ophthalmic solution) 0.5%
Company: AllerganApproval Status: Approved January 1997
Treatment for: Treatment for postoperative inflammation in patients who have undergone cataract extraction
Areas: Eye Health / Ophthalmology
Possible similar drugs: Acular
General Information
Acular has been approved for the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Acular Drug Information
The Acular drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
